Citation: Tm. Wall et al., PRESERVATION OF CORONARY-ARTERY ENDOTHELIAL-MEDIATED VASODILATION BY CHRONIC ORAL-ADMINISTRATION OF PROBUCOL IN A UNIQUE IN-VIVO RABBIT MODEL OF CHOLESTEROL-INDUCED ENDOTHELIAL DYSFUNCTION, Circulation, 96(8), 1997, pp. 3397-3397
Citation: Tm. Wall et al., RAMIPRILAT ATTENUATES HYPOXIA REOXYGENATION INJURY TO CARDIAC MYOCYTES VIA A BRADYKININ-DEPENDENT MECHANISM/, European journal of pharmacology, 306(1-3), 1996, pp. 165-174
Citation: Tm. Wall et al., THE TEMPORAL RELATIONSHIP BETWEEN BRADYKININ AND K-ATP CHANNELS IN THE MECHANISM OF CARDIOPROTECTIVE ISCHEMIC PRECONDITIONING, Circulation, 92(8), 1995, pp. 1203-1203
Authors:
HARTMAN JC
ANDERSON DC
WILTSE AL
LANE CL
ROSENBLOOM CL
MANNING AM
HUMPHREY WR
WALL TM
SHEBUSKI RJ
Citation: Jc. Hartman et al., PROTECTION OF ISCHEMIC REPERFUSED CANINE MYOCARDIUM BY CL18/6, A MONOCLONAL-ANTIBODY TO ADHESION MOLECULE ICAM-1/, Cardiovascular Research, 30(1), 1995, pp. 47-54
Citation: Jc. Hartman et al., INHIBITION OF NITRIC-OXIDE SYNTHASE PREVENTS MYOCARDIAL PROTECTION BYRAMIPRILAT, The Journal of pharmacology and experimental therapeutics, 270(3), 1994, pp. 1071-1076
Citation: Tm. Wall et al., ROLE OF BRADYKININ IN MYOCARDIAL PRECONDITIONING, The Journal of pharmacology and experimental therapeutics, 270(2), 1994, pp. 681-689
Citation: Da. Linseman et al., THE TROLOX ANALOG, U-78517F, ATTENUATES HYPOXIC INJURY IN ISOLATED CARDIAC MYOCYTES, Journal of Molecular and Cellular Cardiology, 26(9), 1994, pp. 1249-1257
Citation: Tm. Wall et al., BRADYKININ RELATED CARDIOPROTECTION IN ISCHEMIC PRECONDITIONING IS MEDIATED BY K(ATP) CHANNELS, Circulation, 90(4), 1994, pp. 475-475
Citation: Tm. Wall et al., BRADYKININ RELATED CARDIOPROTECTION IN ISCHEMIC PRECONDITIONING IS MEDIATED BY K(ATP) CHANNELS, Circulation, 90(4), 1994, pp. 475-475
Citation: Jc. Hartman et al., REDUCTION OF MYOCARDIAL INFARCT SIZE IN RABBITS BY RAMIPRILAT - REVERSAL BY THE BRADYKININ ANTAGONIST HOE-140, Journal of cardiovascular pharmacology, 21(6), 1993, pp. 996-1003
Citation: Jc. Hartman et al., REDUCTION OF MYOCARDIAL INFARCT SIZE BY RAMIPRILAT IS INDEPENDENT OF ANGIOTENSIN-II SYNTHESIS INHIBITION, European journal of pharmacology, 234(2-3), 1993, pp. 229-236